Lampertheim, Germany

Rolf Juchem


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rolf Juchem: Innovator in Pharmaceutical Chemistry

Introduction

Rolf Juchem is a notable inventor based in Lampertheim, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on phenylpyridine derivatives. His research focuses on compounds that have potential applications in the treatment and prevention of serious illnesses, including cancer.

Latest Patents

Rolf Juchem holds a patent for phenylpyridine derivatives, which includes compounds of formula I, their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers, and racemates. This patent also covers the preparation of these compounds, pharmaceutical compositions containing them, and their use in controlling or preventing illnesses such as cancer. He has 1 patent to his name, showcasing his innovative approach to drug development.

Career Highlights

Juchem is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this esteemed organization has allowed him to contribute to groundbreaking research and development in the field of medicine. His expertise and dedication have positioned him as a valuable asset in the pursuit of new therapeutic solutions.

Collaborations

Throughout his career, Rolf Juchem has collaborated with talented professionals, including Birgit Bossenmaier and Thomas Friess. These collaborations have fostered an environment of innovation and creativity, leading to advancements in pharmaceutical research.

Conclusion

Rolf Juchem's contributions to pharmaceutical chemistry, particularly through his patent on phenylpyridine derivatives, highlight his role as an innovator in the field. His work continues to inspire advancements in the treatment of serious illnesses, making a significant impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…